Search Results
Results found for "Terry Kenakin"
- 📰 GPCR Weekly News, March 11 to 17, 2024
Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr.
- 📰 GPCR Weekly News, February 26 to March 3, 2024
Terry Kenakin, was a resounding success; we have a waitlist for those eager to attend this course, which
- 📰 GPCR Weekly News, February 5 to 11, 2024
Terry Kenakin.
- 📰 GPCR Weekly News, February 19 to 25, 2024
Terry Kenakin. We would like to extend our heartfelt thanks to Dr. Kenakin for his invaluable contributions and to all the participants for their active involvement and Chain Reaction Orphan GPR52 as an emerging neurotherapeutic target Sustained antidepressant effects of ketamine
- 📰 GPCR Weekly News, May 27 to June 2, 2024
Terry Kenakin will return for two consecutive courses in September and October 2024.
- 📰 GPCR Weekly News, February 12 to 18, 2024
Terry Kenakin, have been amazing.
- 📰 GPCR Weekly News, July 1 to 7, 2024
Terry Kenakin. Mark your calendars because registration opens on July 18, 2024!
- 📰 GPCR Weekly News, June 17 to 23, 2024
Terry Kenakin will conduct two back-to-back courses this fall.
- 📰 GPCR Weekly News, May 13 to 19, 2024
Terry Kenakin will return with two back-to-back classes.
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Terry Kenakin.
- 📰 GPCR Weekly News, March 25 to March 31, 2024
Terry Kenakin’s Applying Pharmacology to Drug Discovery course.
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
Ho, ho, ho, GPCR elves! As the year wraps up, we're thrilled to present the final edition of the GPCR Weekly Newsletter for 2024! As researchers, we all understand the importance of data in driving meaningful discoveries and advancing our experiments. At Dr. GPCR, we believe the same principle applies to building a better experience for our online community. We’d love to hear your thoughts on our website and its features so that we can continue to support your work and foster collaborations in the GPCR field. Your feedback will guide us in tailoring resources , tools , and content to meet your needs better and help fuel your research. Thank you for sharing your perspective and helping us shape the future of the Dr. GPCR ecosystem! Best, Yamina & the Dr. GPCR Team This Week’s Highlights: Congratulations to Andrew Tobin for an incredible week filled with prestigious events, including receiving the British Pharmacological Society Vane Medal and switching on the Christmas lights at the University of Glasgow Advanced Research Centre! Activation of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain Luke A Pattison , Rebecca H Rickman , Graham Ladds , Ewan St John Smith , et al. Attention, everyone! This is your last chance before the curtain closes: Classified GPCR News will be accessible only to VIP members next year! Indeed, all the details below will be limited to Premium Members . Don't miss out—upgrade now to keep up with your GPCR updates! Classified GPCR News Let’s dive into the Classified GPCR News from December 9th to 15th, 2024 Industry News When science meets serendipity: How accidental discoveries could revolutionise women’s health Seven unanswered questions about blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's GPCR and TPD Structural Biology Platforms GPCR Events, Meetings, and Webinars December 10 - 12, 2024 | Pharmacology 2024 January 13 - 16, 2025 | PepTalk 2025 January 25 - 29, 2025 | SLAS 2025 February 15 - 16, 2025 | Structural and Functional Approaches in GPCR Drug Discovery February 15 - 19, 2025 | BPS 2025 February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28, 2025 | 10th German Pharm-Tox Summit April 1 - 5, 2025 | XXIII GEM Meeting in 2025 April 3 - 6, 2025 | ASPET 2025 April 14 - 17, 2025 | 20th Drug Discovery Chemistry April 24 - 27, 2025 | American Physiology Summit 2025 April 25 - 30, 2025 | AACR Annual Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 20 - 22, 2025 | SLAS Europe 2025 June 16 - 19, 2025 | BIO International Convention 2025 July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist, Medicinal Chemistry PhD fellowship in GPCR mechanosensing Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group Postdoctoral Scholar – iPSC in cardiac and endothelial cell function Protein Biochemist/Structural Biologist GPCR Activation and Signaling Activation of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain Regulation of the chemokine receptors CXCR4 and ACKR3 by receptor activity-modifying proteins Single-cell transcriptomics of vomeronasal neuroepithelium reveals a differential endoplasmic reticulum environment amongst neuronal subtypes Methods & Updates in GPCR Research High-throughput optimisation of protein secretion in yeast via an engineered biosensor Optimized vector for functional expression of the human bitter taste receptor TAS2R14 in HEK293 cells Reviews, GPCRs, and more The role of the endocannabinoid system in the pathogenesis and treatment of epilepsy Become a Premium Member! Get your 5-day free trial TODAY!
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
Kenakin walks through this as a living system , showing how GPCRs exist in multiple conformations and Allosteric Interactions Only in Terry’s Corner 🎬 Plus New: Lesson Trailers Curious about Terry’s Corner Kenakin 💎 $2999/year — one conference cost = 12 months of expert training Premium Dr. That’s where Terry’s Corner changes the game. Subscribe to The Kenakin Brief today ➤
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
. 👉 Unlock Irreversible Drugs — Only in Terry’s Corner! Kenakin will get released next month, featuring real questions from discovery scientists tackling enzyme Kenakin Content trusted by biotech, pharma, and academia 💎 $2999/year — one conference cost = a full Kenakin with your own enzyme or GPCR interaction puzzles. Subscribe to The Kenakin Brief today ➤
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
Terry's Corner - New Course on Pharmacologic Models The latest Terry’s Corner unlocks clinical forecasting Kenakin. I wish Dr.
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
This week Terry's Corner unlocks a simple lever that separates signal from storytelling, moving programs Terry's Corner – Assay Volume Control in GPCR Drug Discovery This week in Terry’s Corner, you’ll learn 🎬 Plus New: Lesson Trailers Curious about Terry’s Corner before committing? Kenakin every last Thursday of the month at 12pm EST 7-day free trial to explore the corner 💎 $2999 Kenakin. I wish Dr.
- Episode 86 of the Dr. GPCR podcast with Dr. Nicole (Nicki) Perry-Hauser is now available!
Nicole (Nicki) Perry-Hauser is now available What a fun chat! 📹Would you like to see the video?
- How Fast Does a Drug Work?
Kenakin’s latest lecture delivers exclusive, real-world insight designed to equip you to move beyond Kenakin’s kinetic insights help you translate assay readouts into actionable knowledge that keeps your But as Kenakin shows in this lecture, the reality is more nuanced, and mastering drug binding kinetics Kenakin’s lecture guides you through key questions that should shape your decision-making process: Are Kenakin gives you clear, practical guidance on when to look deeper and how to extract meaningful, operational
- The Five Traps of Ignoring Kinetics
Unlock “Kinetics: Advanced Applications” Only in Terry’s Corner Why Terry’s Corner Most pharmacology That’s where Terry’s Corner changes the game. experience Whether you’re validating assays, refining kinetic models, or deciding which leads to advance, Terry Subscribe to The Kenakin Brief today ➤
- Curve Shifts Don’t Lie, But Your Eyes Might
Unlock “Statistical Analysis” now Only in Terry’s Corner Why Terry’s Corner Your work demands clarity Terry’s Corner is designed to give you the edge. pharmacology experience Whether you’re validating assays, refining models, or deciding which leads to advance, Terry Subscribe to The Kenakin Brief today ➤ #ttest #ANOVA #poweranalysis #curvecomparison #ftest #assayvalidation
- From Snapshots to Predictions: Why Mechanism of Action Matters
This week in Terry's Corner you'll learn how model-based thinking helps you determine a drug’s mechanism Take the example Terry highlights: an agonist curve with a rightward shift and elevated baseline. Unlock “Mechanism of Action” now Only in Terry’s Corner Why Terry’s Corner When early choices determine Terry’s Corner is designed to give you the edge. Subscribe to The Kenakin Brief today ➤
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Terry's Corner – How Enzyme Inhibition Shapes Every Discovery Program Every molecule meets an enzyme This week’s Terry’s Corner reframes inhibition not as background theory—but as a design lens for smarter Kenakin — October 30, 12 PM EST Bring your toughest pharmacology questions and join Dr. Kenakin live. Each session shapes next month’s lessons—so your challenges guide the content. Kenakin Trusted insights across biotech, pharma, and academia 💎 $2,999/year — one conference cost =
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
This week, Terry’s Corner takes you beyond curve shapes into the kinetic and mechanistic realities that Terry's Corner - Demystifying Antagonism: The Key to Precision Drug Discovery Understanding the nuances Kenakin’s expert guidance provides a clear framework for distinguishing these mechanisms and avoiding Premium Members get 50%+ discount when they join Terry’s Corner. Keywords: GPCR, drug discovery, pharmacology, antagonism, competitive, non-competitive, Terry's Corner
- Why Opposing Processes Matter for Your Next GPCR Drug
Terry illustrates this with classic β-receptor partial agonists, showing how heart rate set-points under Terry’s Corner exists to fix that blind spot. Why Terry’s Corner Most pharmacology training freezes at equilibrium snapshots. Subscribe to The Kenakin Brief today ➤
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
Terry's Corner – Orthosteric vs. This week in Terry's Corner, we focuse on the distinction between orthosteric and allosteric mechanisms overdose risk without sacrificing meaningful efficacy. 🎬 Plus New: Lesson Trailers Curious about Terry Kenakin 💎 $2999/year — one conference cost = 12 months of expert training Premium Dr.
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Terry's Corner – Designing Drugs That Anticipate Physiological Pushback Most GPCR programs don’t fail This week’s Terry’s Corner exposes the unseen physiological “opponents” your molecule faces—and how
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Terry W. Moore, was most definitely a success.
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
While these signaling pathways are highly interconnected, they can also be regulated independently (Kenakin Kenakin, T. (2019). Biased receptor signaling in drug discovery.
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
In: Kenakin TP, editor A Pharmacology Primer (Sixth Edition). Kenakin TP. Kenakin TP. Kenakin T. The mass action equation in pharmacology. Kenakin T. Biased Receptor Signaling in Drug Discovery.